Here, we identified that DLBCL cell lines characterized by HRR gene overexpression [16] are more resistant to PARPi whereas NHEJ gene overexpression [16] is associated with resistance to DNA‐PK and ATM inhibitors (Figure S2). This evidence concerns the gene ATM and diffuse large B-cell lymphoma.